|
|
|
Insider
Information: |
Scanlon Meghan |
Relationship: |
|
City: |
Marlborough |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
50,668 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,017,968 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
50,668 |
|
|
Total
Value |
$2,017,968 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Boston Scientific Corp |
BSX |
SVP,Pres,Urology Pelvi... |
2022-05-01 |
24,461 |
2020-02-21 |
0 |
Premium* |
|
Paragon 28, Inc. |
FNA |
|
2023-05-17 |
26,207 |
2022-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
FNA |
Paragon 28, Inc. |
|
|
2023-05-17 |
4 |
A |
$0.00 |
$0 |
D/D |
8,361 |
26,207 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
|
2022-05-01 |
4 |
D |
$42.11 |
$25,519 |
D/D |
(606) |
24,461 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
|
2022-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,062 |
25,067 |
0 |
- |
|
FNA |
Paragon 28, Inc. |
Director |
|
2022-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
17,846 |
17,846 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
|
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,019 |
23,305 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
|
2022-02-28 |
4 |
D |
$44.17 |
$13,251 |
D/D |
(300) |
23,005 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
|
2022-02-21 |
4 |
D |
$42.55 |
$9,744 |
D/D |
(229) |
22,286 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
|
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
779 |
22,515 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
|
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,112 |
22,063 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
|
2022-02-18 |
4 |
D |
$42.55 |
$13,914 |
D/D |
(327) |
21,736 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
|
2022-02-17 |
4 |
D |
$42.83 |
$21,158 |
D/D |
(494) |
20,951 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
|
2022-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,583 |
21,445 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
|
2022-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,108 |
20,250 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
|
2022-02-15 |
4 |
D |
$44.01 |
$17,076 |
D/D |
(388) |
19,862 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
|
2021-07-27 |
4 |
AS |
$45.01 |
$623,389 |
D/D |
(13,850) |
19,142 |
0 |
% |
|
BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
|
2021-07-27 |
4 |
OE |
$23.41 |
$324,229 |
D/D |
13,850 |
32,992 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
|
2021-07-01 |
4 |
D |
$43.36 |
$10,883 |
D/D |
(251) |
18,434 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
|
2021-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
855 |
18,685 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
|
2021-06-24 |
4 |
AS |
$44.03 |
$724,294 |
D/D |
(16,450) |
17,830 |
0 |
% |
|
BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
|
2021-06-24 |
4 |
OE |
$17.26 |
$283,927 |
D/D |
16,450 |
34,280 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
|
2021-05-01 |
4 |
D |
$43.60 |
$26,378 |
D/D |
(605) |
17,830 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
|
2021-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,061 |
18,435 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
|
2021-02-28 |
4 |
D |
$38.78 |
$11,595 |
D/D |
(299) |
16,374 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
|
2021-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,018 |
16,673 |
0 |
- |
|
BSX |
Boston Scientific Corp |
SVP,Pres,Urology Pelvic Health |
|
2021-02-22 |
4 |
D |
$39.20 |
$13,250 |
D/D |
(338) |
15,655 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|